What is PLTS's health score?

Platinum Analytics Cayman Ltd (PLTS) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PLTS's estimated fair value?

Based on our 5-year discounted cash flow model, Platinum Analytics Cayman Ltd's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is PLTS undervalued or overvalued?

Our model currently rates PLTS as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

Platinum Analytics Cayman Ltd (PLTS)

Technology Inconclusive inconclusive weak

$17.5

Updated: 2026-07-14

TradeApes Score

Financial Strength

40 Weak

Operating Trend

18 Stressed

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk Management

80 Strong

Key Findings

+ High gross margin — above 50%, indicating strong pricing power

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Industry Related Stocks

ACI WORLDWIDE, INC. (ACIW) ADOBE INC. (ADBE) Autodesk, Inc. (ADSK) AUDIOEYE INC (AEYE) C3.ai, Inc. (AI) FIREFLY NEUROSCIENCE, INC. (AIFF)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.